70 participants
Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-10-06
- Start Date:
- 2023-06-27
- Completion:
- 2025-09-04
Conditions
- Cystic Fibrosis
Interventions
- DRUG
No Results Yet